Psychiatry AtlasMedication guide · United States

Antidepressant that acts on serotonin and norepinephrine, two brain messengers

Desvenlafaxine (Pristiq)

Generic name
desvenlafaxine (as desvenlafaxine succinate monohydrate)
Brand names
Pristiq
Medication class
SNRI antidepressant
Forms covered
Pristiq extended-release oral tablets

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

FDA Boxed Warning

Pristiq extended-release oral tablets.

Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Monitor people of all ages for worsening mood and emerging suicidal thinking, particularly when treatment starts or changes. Pristiq is not approved for pediatric use.

Desvenlafaxine (Pristiq) treats major depression in adults. This article covers the extended-release tablet.

What to expect: Depression improvement develops gradually, and fuller benefit may take several weeks.

Warning signs
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Major depressive disorder — Adults. Treatment of major depressive disorder in adults; not an approval for pediatric depression or every anxiety condition.Pristiq extended-release oral tablets.

What should I expect?

Depression improvement develops gradually, and fuller benefit may take several weeks. Follow changes in mood, interest, energy and everyday functioning with the prescriber.

Nausea, sweating, sleep changes or sexual effects may occur before the treatment benefit is clear. Keep follow-up if progress is limited; do not increase or stop the dose yourself.

How do I take it safely?

Take the ER tablet once daily with or without food. Swallow it whole; do not split, crush, chew or dissolve it.

Check blood pressure before and during treatment. Kidney disease can require a lower dose or different schedule; discuss liver disease, bipolar disorder, seizures, low sodium, bleeding risk and narrow eye angles.

Do not combine with venlafaxine or another desvenlafaxine product without explicit review. MAO inhibitors are prohibited: the label requires 14 days after stopping a psychiatric MAOI before Pristiq and seven days after Pristiq before that MAOI. Linezolid and intravenous methylene blue also require special management.

Review other antidepressants, some pain and migraine medicines, St. John’s wort, aspirin, anti-inflammatory pain medicines and blood thinners. Avoid alcohol. Tell testing staff that desvenlafaxine may interfere with some urine drug screening tests.

Reduce gradually with the prescriber; withdrawal may be severe or prolonged and some people need a slow taper over months. Take a missed dose when remembered unless the next is close; skip it then and never double.

Discuss pregnancy and breastfeeding before making changes. Later-pregnancy exposure may affect the newborn or increase maternal complications; older adults need particular attention to kidney function, sodium and dizziness on standing.

What side effects should I know about?

  • Nausea, dizziness, sweating, insomnia or sleepiness.
  • Constipation, reduced appetite, anxiety or sexual difficulties.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • FDA boxed warning: antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults in short-term studies. Monitor everyone for worsening depression, suicidal thinking or unusual behavior, especially when starting or changing a dose. These products are not approved for pediatric use. New suicidal thoughts require immediate clinical contact; immediate danger requires emergency help.
  • Get urgent medical care for fever with confusion or agitation, heavy sweating, diarrhea and stiff or twitching muscles. This combination may be serotonin syndrome, a potentially life-threatening reaction.
  • Contact the prescriber promptly for unusually high energy, very little need for sleep or risky behavior; these can be signs of mania.
  • Severe confusion, unusual bleeding, black stools, or a painful red eye with vision changes needs urgent care. Low sodium, bleeding and sudden eye-pressure increases are possible serious reactions.
  • Report new or worsening cough, shortness of breath or chest discomfort promptly; rare inflammatory lung reactions have been reported.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Do not use after allergy to desvenlafaxine or venlafaxine, or duplicate treatment with either ingredient. MAOI combinations are prohibited: allow at least 14 days after a psychiatric MAOI before Pristiq and seven days after Pristiq before that MAOI. Linezolid and intravenous methylene blue also require specific precautions.
  • Avoid alcohol. Review serotonin medicines, supplements, aspirin, anti-inflammatory pain medicines and blood thinners. Monitor blood pressure; kidney disease can require a different regimen. Bipolar disorder, seizures, liver disease, low sodium, bleeding risk and narrow eye angles also need assessment.
  • Reduce regular treatment gradually with an individual plan; withdrawal can be severe or prolonged. Discuss pregnancy and breastfeeding before making changes: later-pregnancy exposure can affect the newborn and maternal bleeding or blood-pressure risks. Older adults need particular attention to kidney function, sodium and dizziness on standing.
  • Pediatric depression studies did not establish that Pristiq was effective and found weight loss more often than with placebo. It is not approved for children or adolescents. If off-label treatment is considered, discuss the rationale and how weight, appetite, blood pressure and mood will be followed.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • An empty tablet shell in stool can be normal after the medicine has been released. It does not necessarily mean the dose was lost.
  • Higher doses did not show additional benefit in the label studies and caused more side effects. A dose increase is not automatically the answer to a difficult week.
  • Kidney function matters to this medicine’s dosing, including how often it is taken in severe kidney disease.

How does it work?

Desvenlafaxine changes communication between nerve cells by slowing the return of serotonin and norepinephrine, two chemical messengers, into the cells that released them. More of each messenger can then remain available between cells. This is thought to contribute to its antidepressant effect, but it does not establish that depression is caused by a simple shortage of either messenger.

Explore more in Brain & Science: How SNRIs Work: Venlafaxine.

How was this medicine developed?

Pristiq received FDA approval in 2008. Desvenlafaxine is also a substance the body makes while processing venlafaxine; developing it as a separate medicine did not make the two drugs interchangeable.

How do I say the name?

Desvenlafaxine: des-ven-lah-FAX-een. Capital letters show the stressed syllable.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Pristiq: current prescribing information
  2. Pristiq: FDA approval and supplement history
  3. Desvenlafaxine: patient medicine information
  4. Pristiq: FDA prescribing information
  5. Pristiq: Package Insert / Prescribing Information / MOA
  6. Venlafaxine: patient medicine information
  7. Desvenlafaxine: verified neutral parent, PubChem CID 125017
  8. What Is a Neurotransmitter? — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: How Neurotransmitters Work; Types of Neurotransmitters..

  9. ISMP List of Confused Drug Names
  10. Frequently Asked Questions about Labeling for Prescription Medicines | FDA
  11. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  12. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top